Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 348-10-7
2. 2-(2-fluorophenoxy)acetic Acid
3. (2-fluoro-phenoxy)-acetic Acid
4. Acetic Acid, (2-fluorophenoxy)-
5. Mfcd02223229
6. Enamine_002446
7. 2-(2-fluorophenoxy)acetic
8. Schembl257482
9. 2-(2-fluorophenoxy)aceticacid
10. (2-fluorophenyloxy)acetic Acid
11. (2-fluorophenoxy)acetic Acid #
12. Dtxsid80278826
13. [(2-fluorophenyl)oxy]acetic Acid
14. 2-(2-fluorophenoxy)-acetic Acid
15. Hms1400p04
16. Zinc262409
17. Albb-000256
18. Nsc10232
19. Bbl013906
20. Nsc-10232
21. Stk397466
22. (2-fluoro-phenoxy)-aceticacid
23. Akos000104348
24. (2-fluorophenoxy)acetic Acid, Aldrichcpr
25. As-10076
26. Sy008332
27. Db-069079
28. Bb 0217919
29. Cs-0072616
30. Ft-0678443
31. En300-00014
32. A874854
33. J-505621
34. F1791-0537
| Molecular Weight | 170.14 g/mol |
|---|---|
| Molecular Formula | C8H7FO3 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 170.03792224 g/mol |
| Monoisotopic Mass | 170.03792224 g/mol |
| Topological Polar Surface Area | 46.5 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 160 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info :
Registration Country : Italy
Brand Name : JONEXA TROPHIC
Dosage Form : Pre-Filled Syringe
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Spain
Chondroitin Sulfate; Seawater magnesia; Collagen
Brand Name : SCULTUR REFORT
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
25
PharmaCompass offers a list of Collagen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Collagen manufacturer or Collagen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Collagen manufacturer or Collagen supplier.
PharmaCompass also assists you with knowing the Collagen API Price utilized in the formulation of products. Collagen API Price is not always fixed or binding as the Collagen Price is obtained through a variety of data sources. The Collagen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A K-7913 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of K-7913, including repackagers and relabelers. The FDA regulates K-7913 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. K-7913 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of K-7913 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A K-7913 supplier is an individual or a company that provides K-7913 active pharmaceutical ingredient (API) or K-7913 finished formulations upon request. The K-7913 suppliers may include K-7913 API manufacturers, exporters, distributors and traders.
click here to find a list of K-7913 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A K-7913 CEP of the European Pharmacopoeia monograph is often referred to as a K-7913 Certificate of Suitability (COS). The purpose of a K-7913 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of K-7913 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of K-7913 to their clients by showing that a K-7913 CEP has been issued for it. The manufacturer submits a K-7913 CEP (COS) as part of the market authorization procedure, and it takes on the role of a K-7913 CEP holder for the record. Additionally, the data presented in the K-7913 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the K-7913 DMF.
A K-7913 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. K-7913 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of K-7913 suppliers with CEP (COS) on PharmaCompass.
K-7913 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of K-7913 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right K-7913 GMP manufacturer or K-7913 GMP API supplier for your needs.
A K-7913 CoA (Certificate of Analysis) is a formal document that attests to K-7913's compliance with K-7913 specifications and serves as a tool for batch-level quality control.
K-7913 CoA mostly includes findings from lab analyses of a specific batch. For each K-7913 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
K-7913 may be tested according to a variety of international standards, such as European Pharmacopoeia (K-7913 EP), K-7913 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (K-7913 USP).
